1-Bromo-3-phenylpropane - CAS 637-59-2
Catalog: |
BB032266 |
Product Name: |
1-Bromo-3-phenylpropane |
CAS: |
637-59-2 |
Synonyms: |
3-bromopropylbenzene |
IUPAC Name: | 3-bromopropylbenzene |
Description: | 1-Bromo-3-phenylpropane (CAS# 637-59-2) is used in the synthesis of MraY natural inhibitors as antibacterial agents. Also used in the preparation of quinolinone derivatives as potent and selective MAO-B inhibitors. |
Molecular Weight: | 199.09 |
Molecular Formula: | C9H11Br |
Canonical SMILES: | C1=CC=C(C=C1)CCCBr |
InChI: | InChI=1S/C9H11Br/c10-8-4-7-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8H2 |
InChI Key: | XMZQWZJMTBCUFT-UHFFFAOYSA-N |
Boiling Point: | 219-220 °C |
Purity: | 95 % |
Density: | 1.31 g/cm3 |
Appearance: | Colorless to light yellow liqui |
Storage: | Store in a cool, dry place. Store in a tightly closed container. |
MDL: | MFCD00000257 |
LogP: | 3.01410 |
Vapor Pressure: | 0.06 [mmHg] |
GHS Hazard Statement: | H302 (52.7%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113461553-A | Synthesis method of dapoxetine and dapoxetine hydrochloride | 20210323 |
CN-113292523-A | Selective butyrylcholine esterase inhibitor or medicinal salt thereof, and preparation method and application thereof | 20210224 |
CN-112933098-A | Application of griseofulvin tetrazole derivative in preparation of antitumor drugs | 20210207 |
CN-112321425-A | Synthesis method of 4- (3-bromopropyl) methyl benzoate | 20201023 |
CN-112047870-A | Preparation method of 7-alkyl indole derivative | 20201012 |
PMID | Publication Date | Title | Journal |
22463689 | 20120411 | Replacing conventional carbon nucleophiles with electrophiles: nickel-catalyzed reductive alkylation of aryl bromides and chlorides | Journal of the American Chemical Society |
21990014 | 20111104 | Structure-activity relationship for the first-in-class clinical steroid sulfatase inhibitor Irosustat (STX64, BN83495) | ChemMedChem |
19557801 | 20090801 | Improved tricyclic inhibitors of trypanothione reductase by screening and chemical synthesis | ChemMedChem |
16355999 | 20051223 | Synthesis of symmetrical organic carbonates via significantly enhanced alkylation of metal carbonates with alkyl halides/sulfonates in ionic liquid | The Journal of organic chemistry |
16209599 | 20051014 | Room-temperature Negishi cross-coupling of unactivated alkyl bromides with alkyl organozinc reagents utilizing a Pd/N-heterocyclic carbene catalyst | The Journal of organic chemistry |
Complexity: | 74.8 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 198.00441 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 0 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 198.00441 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 0 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Halides
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS